Ferritin as prognostic marker in COVID-19: the FerVid study
- 17 October 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Postgraduate Medicine
- Vol. 134 (1), 58-63
- https://doi.org/10.1080/00325481.2021.1990091
Abstract
Background In COVID-19 patients the progressive clinical deterioration seems secondary to the activation of a cytokine storm. Ferritin is considered a direct mediator of the immune system and some evidences suggested a shared physio-pathogenic basis between COVID-19 and 'Hyperferritinemic Syndromes.' The aim of our study was to evaluate the prognostic role of ferritin in COVID-19 patients. Methods We retrospectively studied consecutive COVID-19 patients admitted to four Italian Internal Medicine Units. Role of potential prognostic markers was evaluated with binary logistic regression analysis and results were expressed as odds ratios (ORs) with the corresponding 95% confidence intervals (CIs). Poor outcome was defined as death or need to transfer in the intensive care unit. Results Two hundred patients were included (mean age 68.75 +/- 13.22 years). Ferritin value was highly elevated (>3000 ng/mL) in 8% of our population; 13% of patients were transferred to intensive care units and 12% of patients died. At multivariate analysis, highly elevated ferritin levels (OR 16.67 C.I. 4.89-57.57 p < 0.001) and hemoglobin < 10 g/dL (OR 8.88 C.I. 2.02-39.09 p = 0.004) were independently associated with a bad outcome. Patients with ferritin values > 3000 ng/ml appeared to have an inflammatory activation with elevated values of CRP and D-dimer and low values of lymphocyte count. Conclusion Our results confirm the prognostic role of ferritin in hospitalized COVID-19 patients. Patients with high ferritin levels should be considered critically ill and treated in an adequate setting. Furthermore, COVID-19 seems to share some characteristics with hyperferritinemic syndromes with potential therapeutic implications.Keywords
This publication has 22 references indexed in Scilit:
- Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like DiseaseAutoimmunity Reviews, 2020
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from ChinaClinical Immunology, 2020
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)Journal of General Internal Medicine, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DICJournal of Intensive Care, 2015
- sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemiaImmunologic Research, 2014
- The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndromeBMC Medicine, 2013
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CThe New England Journal of Medicine, 2012
- New functions for an iron storage protein: The role of ferritin in immunity and autoimmunityJournal of Autoimmunity, 2008